It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Heart failure (HF) is frequently accompanied with the sinoatrial node (SAN) dysfunction, which causes tachy-brady arrhythmias and increased mortality. MicroRNA (miR) alterations are associated with HF progression. However, the transcriptome of HF human SAN, and its role in HF-associated remodeling of ion channels, transporters, and receptors responsible for SAN automaticity and conduction impairments is unknown. We conducted comprehensive high-throughput transcriptomic analysis of pure human SAN primary pacemaker tissue and neighboring right atrial tissue from human transplanted HF hearts (n = 10) and non-failing (nHF) donor hearts (n = 9), using next-generation sequencing. Overall, 47 miRs and 832 mRNAs related to multiple signaling pathways, including cardiac diseases, tachy-brady arrhythmias and fibrosis, were significantly altered in HF SAN. Of the altered miRs, 27 are predicted to regulate mRNAs of major ion channels and neurotransmitter receptors which are involved in SAN automaticity (e.g. HCN1, HCN4, SLC8A1) and intranodal conduction (e.g. SCN5A, SCN8A) or both (e.g. KCNJ3, KCNJ5). Luciferase reporter assays were used to validate interactions of miRs with predicted mRNA targets. In conclusion, our study provides a profile of altered miRs in HF human SAN, and a novel transcriptome blueprint to identify molecular targets for SAN dysfunction and arrhythmia treatments in HF.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 The Ohio State University College of Medicine and Wexner Medical Center, Department of Physiology and Cell Biology, Columbus, USA (GRID:grid.261331.4) (ISNI:0000 0001 2285 7943); The Ohio State University College of Medicine and Wexner Medical Center, Bob and Corrine Frick Center for Heart Failure and Arrhythmia, Dorothy M. Davis Heart & Lung Research Institute, Columbus, USA (GRID:grid.261331.4) (ISNI:0000 0001 2285 7943)
2 The Ohio State University College of Medicine and Wexner Medical Center, Biomedical Informatics Shared Resources, Columbus, USA (GRID:grid.261331.4) (ISNI:0000 0001 2285 7943)
3 The Ohio State University College of Medicine and Wexner Medical Center, Department of Surgery, Division of Cardiac Surgery, Columbus, USA (GRID:grid.261331.4) (ISNI:0000 0001 2285 7943)
4 The Ohio State University College of Medicine and Wexner Medical Center, Department of Physiology and Cell Biology, Columbus, USA (GRID:grid.261331.4) (ISNI:0000 0001 2285 7943)
5 The Ohio State University College of Medicine and Wexner Medical Center, Department of Internal Medicine, Division of Cardiovascular Medicine, Columbus, USA (GRID:grid.261331.4) (ISNI:0000 0001 2285 7943)
6 University of Manchester, Division of Cardiovascular Sciences, Manchester, UK (GRID:grid.5379.8) (ISNI:0000000121662407); Jagiellonian University Medical College, Department of Anatomy, Cracow, Poland (GRID:grid.5522.0) (ISNI:0000 0001 2162 9631)




